American Osteopathic Academy of Addiction Medicine’s Tuesday Program will include an 8-hour Buprenorphine Waiver Training. The training runs from 7:30 a.m. to 4:30 p.m. in Room 5 on the second floor of the convention center.
Medication Assisted Treatment (MAT) of substance use disorders involves a combination of a medication that targets the brain, and psychosocial interventions aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone.
Providers Clinical Support Systems’ MAT intends to provide free, evidence-based resources to train clinicians and the public about the effectiveness of medications used for treating opioid addiction, including buprenorphine, naltrexone and methadone, to more effectively address this public health crisis.
Faculty for this training will be Anthony Dekker, DO, FAOAAM, William Morrone, DO, FACOFP, and Stephen Wyatt, DO, FAOAAM.
They will describe prerequisites for a physician to begin to prescribe buprenorphine in office-based practice and discuss clinically relevant pharmacological characteristics of buprenorphine.
Additionally, faculty will help attendees identify factors to consider in determining if a patient is an appropriate candidate for office-based treatment and provide induction and maintenance protocols. Strategies for integrating psychosocial care with office-based pharmacological treatment and managing of chronic and acute pain in patients in maintenance treatment for opioid dependence will also be covered.